GENE ONLINE|News &
Opinion
Blog

FDA Approval
Trials & Approvals FDA Approval
Jazz Pharma’s Xywav Becomes First FDA Approved Drug for a Rare Neurologic Disease
2021-08-13
Trials & Approvals Liver Disease
Albireo Gets Back-to-Back Approvals for Rare Liver Disease Drug
2021-07-26
Trials & Approvals Chronic Kidney Disease
FDA Okays Bayer’s Kidney Disease Drug, Kicking Off Market Rivalry Against Established SGLT-2 Inhibitors
2021-07-12
Trials & Approvals Acute Lymphoblastic Leukemia
FDA Approves Jazz Pharma’s Rylaze for Treating Common Leukemia in Children
2021-07-04
Trials & Approvals Advanced Systemic Mastocytosis
FDA Greenlights Blueprint Medicines’ Ayvakit for Rare Disease Treatment
2021-06-21
Trials & Approvals
Biogen’s Controversial Alzheimer’s Drug Wins Historic FDA Approval
2021-06-07
Trials & Approvals Bipolar Disorder
Alkermes Overcomes Regulatory Setbacks to Snag FDA Approval for Schizophrenia Drug
2021-06-01
Trials & Approvals Cholangiocarcinoma
FDA Okays Second FGFR Inhibitor for Cholangiocarcinoma, Approves FMI’s CGP Test as Companion Diagnostic
2021-05-31
Trials & Approvals KRAS
We Have a Winner! Amgen Grabs First FDA Nod in the Race for Undruggable KRAS
2021-05-30
Trials & Approvals Type 2 Diabetes
FDA Greenlights AstraZeneca’s Blockbuster Drug for Chronic Kidney Disease
2021-05-02
Trials & Approvals Cancer
GSK’s Oncology Drug Acquired from Tesaro Notches Accelerated Approval for Endometrial Cancer
2021-04-25
Trials & Approvals Gastric Cancer
BMS’s Drug Bags First FDA-Approved Immunotherapy Tag for Initial Treatment of Gastric Cancer
2021-04-19
Trials & Approvals Asthma
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
Trials & Approvals Cancer
Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
Trials & Approvals
BMS, bluebird’s Multiple Myeloma Drug Becomes First BCMA Targeting CAR-T Therapy to Snag FDA Okay
2021-03-28
1 … 4 5 6 7 8 9
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top